Clinical Correspondence
Ruxolitinib for foreign body reaction to silicone in a patient with chronic graft-versus-host disease
Rodolfo David Palacios-Diaz,
Corresponding Author
Rodolfo David Palacios-Diaz
Dermatology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
Dermatology, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
Search for more papers by this author Javier López-Davia,
Javier López-Davia
Dermatology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
Dermatology, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
Search for more papers by this author Juan Montoro Gómez,
Juan Montoro Gómez
Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
Search for more papers by this author Ignacio Torres-Navarro,
Ignacio Torres-Navarro
Dermatology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
Dermatology, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
Search for more papers by this author Rafael Botella-Estrada,
Rafael Botella-Estrada
Dermatology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
Dermatology, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
Department of Medicine, Universitat de València, Valencia, Spain
Search for more papers by this author
Rodolfo David Palacios-Diaz,
Corresponding Author
Rodolfo David Palacios-Diaz
Dermatology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
Dermatology, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
Search for more papers by this author Javier López-Davia,
Javier López-Davia
Dermatology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
Dermatology, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
Search for more papers by this author Juan Montoro Gómez,
Juan Montoro Gómez
Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
Search for more papers by this author Ignacio Torres-Navarro,
Ignacio Torres-Navarro
Dermatology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
Dermatology, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
Search for more papers by this author Rafael Botella-Estrada,
Rafael Botella-Estrada
Dermatology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
Dermatology, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
Department of Medicine, Universitat de València, Valencia, Spain
Search for more papers by this author
First published: 04 July 2024
No abstract is available for this article.
References
- 1Wang LL, Thomas WW, Friedman O. Granuloma formation secondary to silicone injection for soft-tissue augmentation in facial cosmetics: mechanisms and literature review. Ear Nose Throat J. 2018; 97(1–2): 46–51.
- 2Palacios-Diaz RD, Sánchez-Arráez J, Abril-Pérez C, Pozuelo-Ruiz M, Torres-Navarro I, López-Davia J, et al. Foreign body reaction to silicone after hematopoietic stem cell transplantation. Int J Dermatol. 2023; 62(3): e191–e193. https://doi.org/10.1111/ijd.16466
- 3Sood S, Heung M, Georgakopoulos JR, Mufti A, Prajapati VH, Yeung J. Use of Janus kinase inhibitors for granulomatous dermatoses: a systematic review. J Am Acad Dermatol. 2023; 89(2): 357–359. https://doi.org/10.1016/j.jaad.2023.03.024
- 4Braun LM, Zeiser R. Kinase inhibition as treatment for acute and chronic graft-versus-host disease. Front Immunol. 2021; 12: 1–23. https://doi.org/10.3389/fimmu.2021.760199
- 5Hwang AS, Kechter JA, Li X, Hughes A, Severson KJ, Boudreaux B, et al. Topical ruxolitinib in the treatment of necrobiosis lipoidica: a prospective, open-label study. J Invest Dermatol. 2024; 27: 1–8. https://doi.org/10.1016/j.jid.2023.11.027
